rumor
    rumor
    • Screeners
    • Heatmaps
    • Charts
    • News
    • Documentation
    • Pricing
    • FAQ
    You're viewing limited data.
    Log inSign up

    Sign up

    24 hours of full access, free. No credit card.

    Log inPricing
    1 asset

    Market news

    TypeAll
    SortNewest
    Assets
    CGEN
    Type
    TypeAll
    All
    Sort
    SortNewest
    Newest

    Filter by asset

      Compugen Ltd (CGEN) Q3 2026 Earnings Call Highlights: Revenue Doubles as Gilead and AstraZeneca ...

      Compugen Ltd (CGEN) posted $3.8 million in Q3 2026 revenue, completed MAIA-ovarian enrollment with data due by Q1 2027, and holds $117.5 million in cash to fund operations into 2029.

      Nov 12Yahoo FinanceAZNCGENGILD
      Compugen stock maintained at Buy by H.C. Wainwright, $4 target
      Nov 12Investing.comCGEN
      Compugen at Stifel 2026 Healthcare Conference: pipeline, cash and catalysts
      Nov 10Investing.comCGENSF
      Compugen: COM701 Data On Track And Continued Bispecific Rilvegostomig Development (CGEN)
      Nov 10Seeking AlphaCGEN
      Compugen to Present UnigenX™ Platform at the 18th Annual PEGS Europe Summit
      Nov 10Yahoo FinanceCGEN
      Compugen Ltd. Q3 2026 Earnings Call Summary
      Nov 9Yahoo FinanceCGEN
      Compugen (CGEN) Q3 2026 Earnings Call Transcript

      Motley Fool Press Release.

      Nov 9The Globe and MailCGEN
      What Compugen (CGEN) Said on Its Q3 Earnings Call
      Nov 9Yahoo FinanceCGEN
      Earnings call transcript: Compugen tops cash outlook in Q3 2026 as stock jumps
      Nov 9Investing.comCGEN
      Compugen (CGEN) Reports Q3 Loss, Beats Revenue Estimates
      Nov 9Yahoo FinanceCGEN
      Compugen: Q3 Earnings Snapshot

      HOLON, Israel (AP) — HOLON, Israel (AP) — Compugen Ltd. (CGEN) on Monday reported a loss of $5.

      Nov 9Yahoo FinanceCGEN
      Compugen Reports Third Quarter 2026 Results
      Nov 9Yahoo FinanceCGEN
      Earnings To Watch: Compugen Ltd (CGEN) Q3 2026 -- GF Value Sees 243% Upside
      Nov 6Yahoo FinanceCGEN
      Compugen to Participate in November Investor Conferences
      Nov 3Yahoo FinanceCGEN
      Compugen to Release Third Quarter 2026 Results on Monday, November 9, 2026
      Oct 26Yahoo FinanceCGEN
      Analysts Offer Insights on Healthcare Companies: Stoke Therapeutics (STOK) and Compugen (CGEN)

      Tipranks Press Release.

      Oct 7The Globe and MailCGENSTOK
      Compugen (CGEN) Receives a Buy from Oppenheimer

      Detailed price information for Compugen Ltd (CGEN-Q) from The Globe and Mail including charting and trades.

      Oct 7The Globe and MailCGEN
      Stifel Nicolaus Remains a Buy on Compugen (CGEN)

      Detailed price information for Compugen Ltd (CGEN-Q) from The Globe and Mail including charting and trades.

      Oct 7The Globe and MailCGEN
      Stifel reiterates Compugen stock rating on ovarian trial update
      Oct 6Investing.comCGEN
      Compugen to Participate in a Fireside Chat at the H.C. Wainwright 3rd Annual AI Based Drug Discovery & Development Conference

      Compugen Ltd. (NASDAQ: CGEN) (TASE: CGEN) a clinical-stage cancer immunotherapy company and a pioneer in computational target discovery powered by AI, today announced that management will participate in a fireside chat at the H.C. Wainwright 3rd Annual AI Based Drug Discovery & Development Conference, being held virtually on October 8-9, 2026.

      Oct 6Yahoo FinanceCGEN
      Compugen Highlights COM701 Ovarian Trial, Expands AI Platform Into Tumor Targets

      Compugen (NASDAQ:CGEN) outlined the clinical rationale for its COM701 antibody in platinum-sensitive ovarian cancer and described an expansion of its AI-powered discovery platform into tumor-associated antigen, or TAA, research during a company update event. President and Chief Executive Officer Er

      Oct 5Yahoo FinanceCGEN
      Compugen to Host Virtual KOL Event on COM701 in Ovarian Cancer & Unigen™ Platform Update on October 5, 2026
      Sep 22Yahoo FinanceCGEN
      Compugen Shareholders Approve All Proposals at 2026 Annual Meeting

      Detailed price information for Compugen Ltd (CGEN-Q) from The Globe and Mail including charting and trades.

      Sep 11The Globe and MailCGEN
      Compugen to Participate in a Fireside Chat at the H.C. Wainwright 28th Annual Global Investment Conference

      Compugen Ltd. (NASDAQ: CGEN) (TASE: CGEN) a clinical-stage cancer immunotherapy company and a pioneer in computational target discovery powered by AI, today announced that management will participate in a fireside chat and hold one-on-one meetings at the H.C. Wainwright 28th Annual Global Investment Conference, being held from September 14-16 in New York City.

      Sep 8Yahoo FinanceCGEN
      All You Need to Know About Compugen (CGEN) Rating Upgrade to Buy

      Compugen (CGEN) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

      Aug 31Yahoo FinanceCGEN
      Are Medical Stocks Lagging Compugen (CGEN) This Year?

      Here is how Compugen (CGEN) and Envoy Medical, Inc. (COCH) have performed compared to their sector so far this year.

      Aug 21Yahoo FinanceCGENCOCH

      This is the newest page. Registered accounts read further back.